Loading
Loading…
Loading…
| # | Company | Status |
|---|---|---|
| 1 | Admitted-Fee/PreQual/Technical | Admitted-Fee/PreQual/Technical |
| 2 | Admitted-Fee/PreQual/Technical 1ST AND 2ND FLOOR NXT TOWER 2 EMBASSY MANYATA BUSINESS PARK NAGAVARA VILLAGE KASABA HOBLI BANGALORE KARNATAKA INDIA 560045 | BANGALORE | BANGALORE | KARNATAKA | 560045 | Admitted-Fee/PreQual/Technical |
Tender Value
Refer Docs
Closing Date
17 Aug 2026, 11:30 amClosed
Managing Director PHSC
Managing Director, Punjab Health Systems Corporation, Second Floor, E-Block, Punjab School Education Board Complex, Opposite Fortis Hospital, Phase 8 SAS Nagar Mohali
Hemophilia Factors
2026_DHFW_173138_1
PHSC/Proc/2026/38
Open Tender
Medical Equipments/Waste
Item Wise
180 days
SAS Nagar Mohali
As per DNIT
3 documents required · 3 mandatory
₹1,000
Exempted
18 Aug 2026
7 Aug 2026
18 Aug 2026
7 Aug 2026
17 Aug 2026
8 Aug 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1Hemophilia Factors and Chelation Drugs | |||||
| 1.01 | Human Coagulation Factor X 250 IU | 1 | per vial | - | - |
| 1.02 | Factor VIII SHL Recombinant 250 IU | 1 | per vial | - | - |
| 1.03 | Factor VIII SHL Recombinant 500 IU | 1 | per vial | - | - |
| 1.04 | Factor VIII EHL Recombinant 250 IU | 1 | per vial | - | - |
| 1.05 | Factor 9 500 IU EHL Rifixia 500 IU | 1 | per vial | - | - |
| 1.06 | Concizumab 60 mg/1.5 ml | 1 | Per vial | - | - |
| 1.07 | Concizumab 150 mg/1.5 ml | 1 | Per vial | - | - |
stage.html
html • 0.02 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.50 MB
Tendernotice_2.pdf
PDF • 1.00 MB
BOQ_352295.xls
BOQ • 0.32 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .